Main Content

Press Release

Parker Indego Debuts at Craig Hospital in Englewood, Colorado

Craig Hospital is the first of three leading rehabilitation centers within the United States to receive Indego

ENGLEWOOD, CO. –

  • Craig Hospital has been selected and is proud to be part of Indego trial and work with Parker Hannifin
  • Craig is experienced in the use of advanced technology and is looking forward to again be at the forefront of innovation in rehabilitation

Craig Hospital is the first of three leading rehabilitation centers within the United States to receive Indego—a powered lower limb orthosis, also known as exoskeleton—as part of a multicenter study. Indego offers people with impaired mobility a new level of independence by allowing gait impaired individuals to stand and walk. The device enables clinicians to conduct over-ground, task specific gait training.

“The exciting part for us is to test a device that can be used as a therapy tool but as well as a mobility assistive device that patients will be able to take home eventually,” said Candy Tefertiller, Director of Physical Therapy at Craig Hospital.

A selected team at Craig Hospital has been trained by experienced Indego trainers from Shepherd Center in Atlanta, GA, which serves as Parker’s lead rehabilitation center for clinical testing of the device.

“We are very excited to start this trial at Craig Hospital where the team here will play a critical role in collecting meaningful performance data,” said Achilleas Dorotheou, head of the human motion and control business unit for Parker. “Our objective is to bring Indego to market to enable people who were told they would never walk again, to stand upright and walk and provide a new level of independence. We will be working with the best and most respected rehabilitation clinicians and researchers in the country gathering evidence that not only demonstrates the safety of Indego but proves its tangible clinical and economic benefit.”

“At Craig Hospital, it’s important that we not only have the highest quality care, but also provide our patients with the latest in technology and research,” said Mike Fordyce, CEO of Craig Hospital. “We look forward to working with the new Indego and seeing how it can help those we serve.”

Indego is available in the United States only for investigational use until FDA approval has been obtained, which is anticipated for mid 2015. The other centers which have been selected to participate in the Indego trial are the Rehabilitation Institute of Chicago, Kessler Institute for Rehabilitation, NYU Rusk Institute for Rehabilitation and Shepherd Center.